Establishment Labs Holdings Inc. - Common Shares (ESTA) by event type
ESTA moves most on price-target raises — a median of -0.07% at 30 minutes across 26 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ESTA overview →
How ESTA reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Rating reiterations 1,523 of 3,522 | 64 | +0.01% | 50% | +0.18% |
| Price-target raises 1,240 of 1,790 | 26 | -0.07% | 46% | -0.10% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how ESTA usually reacts — get an email when it moves on news →Every name measured for these event types: Rating reiterations → · Price-target raises → · ESTA overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
| Adverum Biotechnologies, Inc. (ADVM) | 306 | 0.00% | 49% |
| Syndax Pharmaceuticals, Inc. (SNDX) | 306 | +0.04% | 51% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 305 | +0.42% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.